Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Spinal Cord Neoplasms 1Sarcoma, Kaposi 1Sarcoma 1Optic Nerve Glioma 1Medulloblastoma 1Familial ependymoma 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Astrocytoma 1AIDS-related Kaposi sarcoma 1

Interventions

Vincristine 9Cyclophosphamide 8Cisplatin 7Radiotherapy 6Platinum 51,2-diaminocyclohexaneplatinum II citrate 5Radiation 4Lomustine 4Filgrastim 4Etoposide 4Carboplatin 4Magnetic Resonance Spectroscopy 3Irinotecan 3Granulocyte Colony-Stimulating Factor 3sodium thiosulfate 2merphos 2Temozolomide 2Specimen Handling 2Psychiatric Rehabilitation 2Methotrexate 2sonidegib 1silmitasertib 1sargramostim 1ribociclib 1palbociclib 1omburtamab I-131 1lonafarnib 1laromustine 1emvododstat 1azurin (50-77) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Medulloblastoma × Valproic Acid × Clear all
NCT00107458 2014-08-07

Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

Children's Oncology Group

Phase 1 Completed
26 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡